• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促炎细胞因子与 COVID-19 患者病毒 RNA 持续脱落有关。

Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.

机构信息

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.

出版信息

Clin Immunol. 2020 Dec;221:108611. doi: 10.1016/j.clim.2020.108611. Epub 2020 Oct 14.

DOI:10.1016/j.clim.2020.108611
PMID:33068796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7554496/
Abstract

Since December 2019, Coronavirus Disease 2019 (COVID-19) has emerged as a global pandemic. We aimed to investigate the clinical characteristics and analyzed the risk factors for prolonged viral RNA shedding. We retrospectively collected data from 112 hospitalized COVID-19 patients in a single center in Wuhan, China. Factors associated with prolonged viral RNA shedding (≥28 days) were investigated. Forty-nine (43.8%) patients had prolonged viral RNA shedding. Patients with prolonged viral shedding were older and had a higher rate of hypertension. Proinflammatory cytokines, including interleukin-2R (IL-2R) and tumor necrosis factor-α (TNF-α), were significantly elevated in patients with prolonged viral shedding. Multivariate analysis revealed that hypertension, older age, lymphopenia and elevated serum IL-2R were independent risk factors for prolonged viral shedding. This comprehensive investigation revealed the distinct characteristics between patients with or without prolonged viral RNA shedding. Hypertension, older age, lymphopenia and high levels of proinflammatory cytokines may be correlated with prolonged viral shedding.

摘要

自 2019 年 12 月以来,2019 年冠状病毒病(COVID-19)已成为全球性大流行。本研究旨在调查 COVID-19 患者的临床特征,并分析病毒 RNA 持续排出的危险因素。我们回顾性收集了中国武汉一家中心 112 例住院 COVID-19 患者的数据。研究与病毒 RNA 持续排出(≥28 天)相关的因素。49 例(43.8%)患者的病毒 RNA 持续排出。病毒持续排出的患者年龄较大,且高血压发生率较高。病毒持续排出的患者促炎细胞因子,包括白细胞介素 2 受体(IL-2R)和肿瘤坏死因子-α(TNF-α)明显升高。多因素分析显示,高血压、年龄较大、淋巴细胞减少和血清 IL-2R 升高是病毒 RNA 持续排出的独立危险因素。这项综合研究揭示了具有或不具有病毒 RNA 持续排出的患者之间的明显特征。高血压、年龄较大、淋巴细胞减少和高水平的促炎细胞因子可能与病毒持续排出有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/32bcd5a4c264/mmc6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/05ead3b42099/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/6395fc2edec6/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/9cfe5017b84f/mmc3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/e09728df5839/mmc4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/97b3dc14f206/mmc5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/32bcd5a4c264/mmc6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/05ead3b42099/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/6395fc2edec6/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/9cfe5017b84f/mmc3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/e09728df5839/mmc4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/97b3dc14f206/mmc5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44d/7554496/32bcd5a4c264/mmc6_lrg.jpg

相似文献

1
Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.促炎细胞因子与 COVID-19 患者病毒 RNA 持续脱落有关。
Clin Immunol. 2020 Dec;221:108611. doi: 10.1016/j.clim.2020.108611. Epub 2020 Oct 14.
2
Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: A retrospective study in two designated hospitals in Anhui, China.洛匹那韦/利托那韦与干扰素联合治疗可能有助于缩短 COVID-19 患者的病毒脱落持续时间:中国安徽两家定点医院的回顾性研究。
J Med Virol. 2020 Nov;92(11):2666-2674. doi: 10.1002/jmv.26127. Epub 2020 Jun 29.
3
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.与 SARS-CoV-2 感染住院非重症患者病毒持续排出相关因素及洛匹那韦/利托那韦治疗的影响。
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.00799-2020. Print 2020 Jul.
4
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.COVID-19 患者中 SARS-CoV-2 病毒持续排出与阿比多尔治疗开始延迟和就诊时间推迟有关:一项回顾性队列研究。
Curr Med Sci. 2021 Dec;41(6):1096-1104. doi: 10.1007/s11596-021-2434-y. Epub 2021 Sep 13.
5
Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.洛匹那韦-利托那韦与羟氯喹治疗轻度至中度 2019 冠状病毒病患者病毒清除和临床改善的比较。
Korean J Intern Med. 2021 Mar;36(Suppl 1):S253-S263. doi: 10.3904/kjim.2020.224. Epub 2020 Jun 16.
6
Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19.新型冠状病毒肺炎患者病毒 RNA 脱落持续时间与临床特征和治疗方案的相关性。
Int J Infect Dis. 2020 Sep;98:252-260. doi: 10.1016/j.ijid.2020.06.091. Epub 2020 Jun 30.
7
Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.SARS-CoV-2 RNA 脱落持续时间及 COVID-19 患者病毒脱落时间延长的相关因素。
J Med Virol. 2021 Jan;93(1):506-512. doi: 10.1002/jmv.26280. Epub 2020 Jul 15.
8
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.在预后不良的癌症患者中,SARS-CoV-2 RNA 病毒持续排出和淋巴细胞减少是 COVID-19 的特征。
Cell Death Differ. 2021 Dec;28(12):3297-3315. doi: 10.1038/s41418-021-00817-9. Epub 2021 Jul 6.
9
Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study.洛匹那韦/利托那韦与羟氯喹治疗轻中度 COVID-19 疗效比较:一项全国性倾向评分匹配队列研究。
Int J Infect Dis. 2021 Jan;102:275-281. doi: 10.1016/j.ijid.2020.10.062. Epub 2020 Oct 27.
10
Immune dysregulation and system pathology in COVID-19.COVID-19 中的免疫失调与系统病理学。
Virulence. 2021 Dec;12(1):918-936. doi: 10.1080/21505594.2021.1898790.

引用本文的文献

1
The immune landscape and viral shedding of Omicron SARS-CoV-2 variants implicate immune escape.奥密克戎 SARS-CoV-2 变体的免疫格局和病毒脱落表明存在免疫逃逸。
Front Med (Lausanne). 2025 Jan 22;11:1478466. doi: 10.3389/fmed.2024.1478466. eCollection 2024.
2
Machine learning based predictive modeling and risk factors for prolonged SARS-CoV-2 shedding.基于机器学习的预测模型和 SARS-CoV-2 延长脱落的风险因素。
J Transl Med. 2024 Nov 22;22(1):1054. doi: 10.1186/s12967-024-05872-7.
3
The critical impacts of cytokine storms in respiratory disorders.

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Long-term infection of SARS-CoV-2 changed the body's immune status.新冠病毒长期感染改变了人体的免疫状态。
Clin Immunol. 2020 Sep;218:108524. doi: 10.1016/j.clim.2020.108524. Epub 2020 Jul 11.
3
Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.
细胞因子风暴在呼吸系统疾病中的关键影响。
Heliyon. 2024 Apr 17;10(9):e29769. doi: 10.1016/j.heliyon.2024.e29769. eCollection 2024 May 15.
4
Longitudinal study of disease severity and external factors in cognitive failure after COVID-19 among Indonesian population.印尼人群 COVID-19 后认知功能障碍严重程度及外在因素的纵向研究。
Sci Rep. 2023 Nov 8;13(1):19405. doi: 10.1038/s41598-023-46334-2.
5
In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study.奥密克戎变异株感染的慢性肾脏病患者住院不良结局及其危险因素:一项单中心回顾性研究。
BMC Infect Dis. 2023 Oct 18;23(1):698. doi: 10.1186/s12879-023-08620-2.
6
Different effects of vaccine on VST in critical and non-critical COVID-19 patients: A retrospective study of 363 cases.疫苗对重症和非重症COVID-19患者疫苗特异性T细胞的不同影响:一项363例病例的回顾性研究
Heliyon. 2023 May;9(5):e16017. doi: 10.1016/j.heliyon.2023.e16017. Epub 2023 May 1.
7
Post-COVID depression and its multiple factors, does Favipiravir have a protective effect? A longitudinal study of indonesia COVID-19 patients.新冠后抑郁及其多种因素,法匹拉韦是否具有保护作用?一项对印度尼西亚 COVID-19 患者的纵向研究。
PLoS One. 2022 Dec 30;17(12):e0279184. doi: 10.1371/journal.pone.0279184. eCollection 2022.
8
The impacts of vaccination status and host factors during early infection on SARS-CoV-2 persistence:a retrospective single-center cohort study.疫苗接种状态和早期感染期间宿主因素对 SARS-CoV-2 持续存在的影响:一项回顾性单中心队列研究。
Int Immunopharmacol. 2023 Jan;114:109534. doi: 10.1016/j.intimp.2022.109534. Epub 2022 Nov 30.
9
The correlation between viral shedding duration and blood biomarkers in COVID-19-infected patients.新型冠状病毒肺炎(COVID-19)感染患者病毒脱落持续时间与血液生物标志物之间的相关性。
J Res Med Sci. 2022 Jun 30;27:43. doi: 10.4103/jrms.jrms_401_21. eCollection 2022.
10
Prolonged fever and exaggerated hypercoagulopathy in malaria vivax relapse and COVID-19 co-infection: a case report.疟原虫 vivax 复发和 COVID-19 合并感染时出现长期发热和明显高凝状态:一例报告。
Malar J. 2022 Jun 23;21(1):199. doi: 10.1186/s12936-022-04215-5.
罗沙司他抑制细胞因子信号转导及其在 COVID-19 治疗中的意义。
Clin Immunol. 2020 Sep;218:108517. doi: 10.1016/j.clim.2020.108517. Epub 2020 Jun 23.
4
Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study.中国武汉 301 例 COVID-19 患者的实时逆转录聚合酶链反应检测结果动态特征:一项描述性研究。
J Clin Virol. 2020 Jun;127:104346. doi: 10.1016/j.jcv.2020.104346. Epub 2020 Apr 11.
5
Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19.与 COVID-19 住院患者病毒 RNA 阴转相关的因素。
Sci Total Environ. 2020 Aug 1;728:138812. doi: 10.1016/j.scitotenv.2020.138812. Epub 2020 Apr 22.
6
False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.2019冠状病毒病中逆转录聚合酶链反应的假阴性及核酸转换延长:而非复发
J Med Virol. 2020 Oct;92(10):1755-1756. doi: 10.1002/jmv.25855. Epub 2020 Jul 11.
7
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.大剂量静脉注射免疫球蛋白作为新型冠状病毒肺炎病情恶化患者的一种治疗选择
Open Forum Infect Dis. 2020 Mar 21;7(3):ofaa102. doi: 10.1093/ofid/ofaa102. eCollection 2020 Mar.
8
SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standards for discharge.出院的 COVID-19 患者新冠病毒检测呈阳性,这引发了人们对目前出院标准的关注。
Int J Infect Dis. 2020 Aug;97:212-214. doi: 10.1016/j.ijid.2020.03.007. Epub 2020 Mar 19.
9
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients.老年 COVID-19 患者的临床特征:与中青年患者的比较。
J Infect. 2020 Jun;80(6):e14-e18. doi: 10.1016/j.jinf.2020.03.005. Epub 2020 Mar 27.
10
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.